ArticleMolecular cancer therapeutics2026

Farnesyl Transferase Inhibitor KO-2806 (Darlifarnib) Enhances the Antitumor Activity of Tyrosine Kinase Inhibitors in RCC.

Jovylyn G Gasendo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.